[1] POZZI A, POLIZZI G, MOY PK. Guided surgery with tooth-supported templates for single missing teeth: A critical review. Eur J Oral Implantol. 2016;9 Suppl 1:S135-153.
[2] CHRCANOVIC BR, ALBREKTSSON T, WENNERBERG A. Reasons for failures of oral implants. J Oral Rehabil. 2014;41(6):443-476.
[3] DE MEDEIROS F, KUDO GAH, LEME BG, et al. Dental implants in patients with osteoporosis: a systematic review with meta-analysis. Int J Oral Maxillofac Surg. 2018;47(4):480-491.
[4] DEREKA X, CALCIOLARI E, DONOS N, et al. Osseointegration in osteoporotic-like condition: A systematic review of preclinical studies. J Periodontal Res. 2018;53(6):933-940.
[5] POKROWIECKI R. The paradigm shift for drug delivery systems for oral and maxillofacial implants. Drug Deliv. 2018;25(1):1504-1515.
[6] VALLET-REGí M, BALAS F, ARCOS D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl. 2007;46(40):7548-7558.
[7] JEONG J, KIM JH, SHIM JH, et al. Bioactive calcium phosphate materials and applications in bone regeneration. Biomater Res. 2019;23:4.
[8] SADAT-SHOJAI M, KHORASANI MT, DINPANAH-KHOSHDARGI E, et al. Synthesis methods for nanosized hydroxyapatite with diverse structures. Acta Biomater. 2013;9(8):7591-7621.
[9] RUIXIN L, CHENG X, YINGJIE L, et al. Degradation behavior and compatibility of micro, nanoHA/chitosan scaffolds with interconnected spherical macropores. Int J Biol Macromol. 2017;103:385-394.
[10] SZCZEŚ A, HOŁYSZ L,CHIBOWSKI E. Synthesis of hydroxyapatite for biomedical applications. Adv Colloid Interface Sci. 2017;249: 321-330.
[11] REHMAN F, RAHIM A, AIROLDI C, et al. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release. Mater Sci Eng C Mater Biol Appl. 2016;59:970-979.
[12] BALLO AM, BJööRN D, ASTRAND M, et al. Bone response to physical-vapour-deposited titanium dioxide coatings on titanium implants. Clin Oral Implants Res. 2013;24(9):1009-1017.
[13] BERINGER LT, KIECHEL MA, KOMIYA Y, et al. Osteoblast biocompatibility of novel chitosan crosslinker, hexamethylene-1,6-diaminocarboxysulfonate. J Biomed Mater Res A. 2015;103(9):3026-3033.
[14] WU S, ZHOU Y, YU Y, et al. Evaluation of Chitosan Hydrogel for Sustained Delivery of VEGF for Odontogenic Differentiation of Dental Pulp Stem Cells. Stem Cells Int. 2019;2019:1515040.
[15] RODRíGUEZ-VáZQUEZ M, VEGA-RUIZ B, RAMOS-ZúñIGA R, et al. Chitosan and Its Potential Use as a Scaffold for Tissue Engineering in Regenerative Medicine. Biomed Res Int. 2015;2015:821279.
[16] AHMED TA,ALJAEID BM. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther. 2016;10:483-507.
[17] ZHANG Z, TONGCHUSAK S, MIZUKAMI Y, et al. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials. 2011;32(14):3666-3678.
[18] GUIMARãES MR, LEITE FR, SPOLIDORIO LC, et al. Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK. Arch Oral Biol. 2013;58(10):1309-1317.
[19] CHUNG MF, CHIA WT, LIU HY, et al. Inflammation-induced drug release by using a pH-responsive gas-generating hollow-microsphere system for the treatment of osteomyelitis. Adv Healthc Mater. 2014;3(11):1854-1861.
[20] XUE B, ZHANG C, WANG Y, et al. A novel controlled-release system for antibacterial enzyme lysostaphin delivery using hydroxyapatite/chitosan composite bone cement. PLoS One. 2014;9(12):e113797.
[21] KORN P, SCHULZ MC, HINTZE V, et al. Chondroitin sulfate and sulfated hyaluronan-containing collagen coatings of titanium implants influence peri-implant bone formation in a minipig model. J Biomed Mater Res A. 2014;102(7):2334-2344.
[22] CHEN H, GIGLI M, GUALANDI C, et al. Tailoring chemical and physical properties of fibrous scaffolds from block copolyesters containing ether and thio-ether linkages for skeletal differentiation of human mesenchymal stromal cells. Biomaterials. 2016;76:261-272.
[23] KOOLEN M, LONGONI A, VAN DER STOK J, et al. Complete regeneration of large bone defects in rats with commercially available fibrin loaded with BMP-2. Eur Cell Mater. 2019;38:94-105.
[24] SUN B, ZHANG M, SHEN J, et al. Applications of Cellulose-based Materials in Sustained Drug Delivery Systems. Curr Med Chem. 2019; 26(14):2485-2501.
[25] LI EC, DAVIS LE. Zoledronic acid: a new parenteral bisphosphonate. Clin Ther. 2003;25(11):2669-2708.
[26] LIU J, PATHAK JL, HU X, et al. Sustained Release of Zoledronic Acid from Mesoporous TiO(2)-Layered Implant Enhances Implant Osseointegration in Osteoporotic Condition. J Biomed Nanotechnol. 2018;14(11):1965-1978.
[27] PYO SW, KIM YM, KIM CS, et al. Bone formation on biomimetic calcium phosphate-coated and zoledronate-immobilized titanium implants in osteoporotic rat tibiae. Int J Oral Maxillofac Implants. 2014;29(2): 478-484.
[28] JAKOBSEN T, BECHTOLD JE, SOBALLE K, et al. Local delivery of zoledronate from a poly (d,l-lactide)-coating increases fixation of hydroxy-coated implants. J Orthop Res. 2017;35(5):974-979.
[29] ABTAHI J, HENEFALK G, ASPENBERG P. Impact of a zoledronate coating on early post-surgical implant stability and marginal bone resorption in the maxilla-A split-mouth randomized clinical trial. Clin Oral Implants Res. 2019;30(1):49-58.
[30] KISHIMOTO H, NOGUCHI K, TAKAOKA K. Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Jpn Dent Sci Rev. 2019;55(1):95-102.
[31] LIU Y, ZHENG G, LIU L, et al. Inhibition of osteogenesis surrounding the titanium implant by CGRP deficiency. Connect Tissue Res. 2018;59(2): 147-156.
[32] MELELEO D,PICCIARELLI V. Effect of calcium ions on human calcitonin. Possible implications for bone resorption by osteoclasts. Biometals. 2016;29(1):61-79.
[33] HUANG L, LUO Z, HU Y, et al. Enhancement of local bone remodeling in osteoporotic rabbits by biomimic multilayered structures on Ti6Al4V implants. J Biomed Mater Res A. 2016;104(6):1437-1451.
[34] CHEN M, HUANG L, SHEN X, et al. Construction of multilayered molecular reservoirs on a titanium alloy implant for combinational drug delivery to promote osseointegration in osteoporotic conditions. Acta Biomater. 2020;105:304-318.
[35] GALEA GL, PRICE JS, LANYON LE. Estrogen receptors’ roles in the control of mechanically adaptive bone (re)modeling. Bonekey Rep. 2013;2:413.
[36] HARMANKAYA N, KARLSSON J, PALMQUIST A, et al. Raloxifene and alendronate containing thin mesoporous titanium oxide films improve implant fixation to bone. Acta Biomater. 2013;9(6):7064-7073.
[37] MU C, HU Y, HUANG L, et al. Sustained raloxifene release from hyaluronan-alendronate-functionalized titanium nanotube arrays capable of enhancing osseointegration in osteoporotic rabbits. Mater Sci Eng C Mater Biol Appl. 2018;82:345-353.
[38] ELKASABGY NA, ABDEL-SALAM FS, MAHMOUD AA, et al. Long lasting in-situ forming implant loaded with raloxifene HCl: An injectable delivery system for treatment of bone injuries. Int J Pharm. 2019;571:118703.
[39] PROKOPOWICZ M, SZEWCZYK A, SKWIRA A, et al. Biphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery system. Drug Deliv Transl Res. 2020;10(2):455-470.
[40] BOULER JM, PILET P, GAUTHIER O, et al. Biphasic calcium phosphate ceramics for bone reconstruction: A review of biological response. Acta Biomater. 2017;53:1-12.
[41] BOSE S, BANERJEE D, SHIVARAM A, et al. Calcium phosphate coated 3D printed porous titanium with nanoscale surface modification for orthopedic and dental applications. Mater Des. 2018;151:102-112.
[42] PRADO RFD, ANKHA M, BUENO DAG, et al. CaP Coating and Low-Level Laser Therapy to Stimulate Early Bone Formation and Improve Fixation of Rough Threaded Implants. Implant Dent. 2018;27(6):660-666.
[43] HUANG J, LIN D, WEI Z, et al. Parathyroid Hormone Derivative with Reduced Osteoclastic Activity Promoted Bone Regeneration via Synergistic Bone Remodeling and Angiogenesis. Small. 2020;16(6): e1905876.
[44] TANG J, YAN D, CHEN L, et al. Enhancement of local bone formation on titanium implants in osteoporotic rats by biomimetic multilayered structures containing parathyroid hormone (PTH)-related protein. Biomed Mater. 2020;15(4):045011.
[45] YU X, WANG L, JIANG X, et al. Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant. J Mater Sci Mater Med. 2012;23(9):2177-2186.
[46] ARDURA JA, PORTAL-NúñEZ S, LOZANO D, et al. Local delivery of parathyroid hormone-related protein-derived peptides coated onto a hydroxyapatite-based implant enhances bone regeneration in old and diabetic rats. J Biomed Mater Res A. 2016;104(8):2060-2070.
[47] VAN DE PEPPEL J,VAN LEEUWEN JP. Vitamin D and gene networks in human osteoblasts. Front Physiol. 2014;5:137.
[48] CHEN J, DOSIER CR, PARK JH, et al. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors. J Tissue Eng Regen Med. 2016;10(1):40-51.
[49] NASTRI L, MORETTI A, MIGLIACCIO S, et al. Do Dietary Supplements and Nutraceuticals Have Effects on Dental Implant Osseointegration? A Scoping Review. Nutrients. 2020;12(1):268.
[50] MANGANO F, MORTELLARO C, MANGANO N, et al. Is Low Serum Vitamin D Associated with Early Dental Implant Failure? A Retrospective Evaluation on 1625 Implants Placed in 822 Patients. Mediators Inflamm. 2016;2016:5319718.
[51] FRETWURST T, GRUNERT S, WOELBER JP, et al. Vitamin D deficiency in early implant failure: two case reports. Int J Implant Dent. 2016;2(1): 24.
[52] ISOBE K, WATANEBE T, KAWABATA H, et al. Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF). Int J Implant Dent. 2017;3(1):17.
[53] CHEN J,JIANG H. Clinical Application of Concentrated Growth Factor Fibrin Combined With Bone Repair Materials in Jaw Defects. J Oral Maxillofac Surg. 2020;78(7):1041.
[54] XING H, WANG X, XIAO S, et al. Osseointegration of layer-by-layer polyelectrolyte multilayers loaded with IGF1 and coated on titanium implant under osteoporotic condition. Int J Nanomedicine. 2017;12: 7709-7720.
[55] IZQUIERDO-BARBA I, SANTOS-RUIZ L, BECERRA J, et al. Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment. Acta Biomater. 2019;83:456-466.
[56] KIM J, KIM SK, HEO SJ, et al. Bone Formation of Titanium Implant Surfaces Treated with Submicron Poly(lactide-co-glycolide)/Recombinant Human Transforming Growth Factor- β2 Particles by the Electrospray Method: An In Vivo Study. Int J Oral Maxillofac Implants. 2019;34(6):1404-1412.
[57] HAIMOV H, YOSUPOV N, PINCHASOV G, et al. Bone Morphogenetic Protein Coating on Titanium Implant Surface: a Systematic Review. J Oral Maxillofac Res. 2017;8(2):e1.
[58] TENG F, ZHENG Y, WU G, et al. Bone Tissue Responses to Zirconia Implants Modified by Biomimetic Coating Incorporated with BMP-2. Int J Periodontics Restorative Dent. 2019;39(3):371-379.
[59] XU R, SHI G, XU L, et al. Simvastatin improves oral implant osseointegration via enhanced autophagy and osteogenesis of BMSCs and inhibited osteoclast activity. J Tissue Eng Regen Med. 2018;12(5): 1209-1219.
[60] LEE H, LEE H, NA CB, et al. Effects of Simvastatin on the Viability and Secretion of Vascular Endothelial Growth Factor of Cell Spheroids Cultured in Growth Media. Implant Dent. 2018;27(4):480-487.
[61] LIU X, ZHANG Y, LI S, et al. Study of a new bone-targeting titanium implant-bone interface. Int J Nanomedicine. 2016;11:6307-6324.
[62] FANG W, ZHAO S, HE F, et al. Influence of simvastatin-loaded implants on osseointegration in an ovariectomized animal model. Biomed Res Int. 2015;2015:831504.
[63] DUNDAR S,BOZOGLAN A. Evaluation of the effects of topically applied simvastatin on titanium implant osseointegration. J Oral Biol Craniofac Res. 2020;10(2):149-152.
[64] MARX D, RAHIMNEJAD YAZDI A, PAPINI M, et al. A review of the latest insights into the mechanism of action of strontium in bone. Bone Rep. 2020;12:100273.
[65] TAO ZS, ZHOU WS, HE XW, et al. A comparative study of zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats. Mater Sci Eng C Mater Biol Appl. 2016;62:226-232.
[66] LIN G, ZHOU C, LIN M, et al. Strontium-incorporated titanium implant surface treated by hydrothermal reactions promotes early bone osseointegration in osteoporotic rabbits. Clin Oral Implants Res. 2019;30(8):777-790.
[67] ZHAO B, LI X, XU H, et al. Influence of Simvastatin-Strontium-Hydroxyapatite Coated Implant Formed by Micro-Arc Oxidation and Immersion Method on Osteointegration in Osteoporotic Rabbits. Int J Nanomedicine. 2020;15:1797-1807.
|